NCT06695845 2026-02-25A Phase 2 Study of Zanidatamab in Patients With HER2-expressing TumorsJazz PharmaceuticalsPhase 2 Recruiting200 enrolled
NCT04325828 2026-02-13YATAGARASUJanssen Pharmaceutical K.K.Phase 2 Active not recruiting31 enrolled 15 charts
NCT02628067 2025-09-22KEYNOTE 158Merck Sharp & Dohme LLCPhase 2 Active not recruiting1,609 enrolled 5 FDA
NCT05608876 2025-08-07A Clinical Study to Investigate the Efficacy of Tigilanol Tiglate Directly in Head and Neck CancerQBiotics Group LimitedPhase 2 Active not recruiting15 enrolled
NCT06519110 2024-07-25CVL009-C2001Convalife (Shanghai) Co., Ltd.Phase 2 Not yet recruiting60 enrolled
NCT04832438 2022-02-229-ING-41 Plus Carboplatin in Patients With Advanced, Metastatic Salivary Gland CarcinomaActuate Therapeutics Inc.Phase 2 Withdrawn